Sofosbuvir 400mg + Ledipasvir 90mg Tablet

Product Description

Product Details:

• Sofosbuvir 400mg + Ledipasvir 90mg Tablet
• 
  
• Active Ingeridents(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
• Strength : 400 mg + 90 mg
  
• Package: 28 tabs
• Pack Type : Bottle

• The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
• Globally, between 130 to 150 million people globally have chronic hepatitis C infection.
• A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
• There is currently no vaccine for hepatitis C; however research in this area is ongoing.

• injecting drug use through the sharing of injection equipment;
• the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
• the transfusion of unscreened blood and blood products.